a nonsignificant trendp < 0.05
2d, e ) showed a statistically significant decrease in the ovaries of WT mice treated with cisplatin, and a nonsignificant trend toward reduction in WT mice treated with cyclophosphamide (WT saline: 3.15 × 10 9 ± 0.42 × 10 9 μm 3 vs WT cisplatin: 1.54 × 10 9 ± 0.50 × 10 9 μm 3 , p < 0.05; vs WT cyclophosphamide 2.63 × 10 9 ± 0.25 × 10 9 μm 3 , p = 0.19).